Evidence map›Paper›PMID 31210398›Full record

ReviewEuropean journal of heart failure2019

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Perry M Elliott, Aris Anastasakis, Angeliki Asimaki, Cristina Basso, Barbara Bauce, Matthew A Brooke, Hugh Calkins, Domenico Corrado, Firat Duru, Kathleen J Green and 13 more

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in European journal of heart failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review.International journal of environmental research and public health · 2026
    Article
  6. Tailored therapeutics for cardiomyopathies.Nature reviews. Cardiology · 2025
    Review
  7. Article
  8. Left Ventricular Ring-like Pattern: The Arrhythmic Tale of a Scarred Heart.Journal of cardiovascular development and disease · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 6 countries.

Perry M ElliottUniversity College London & St. Bartholomew's Hospital, London, UK.
Aris AnastasakisUnit of Inherited and Rare Cardiovascular Diseases, Onassis Cardiac Surgery Centre, Athens, Greece.
Angeliki AsimakiMolecular and Clinical Sciences Research Institute, St Georges University, London, UK.
Cristina BassoDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua-Azienda Ospedaliera, Padua, Italy.
Barbara BauceDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua-Azienda Ospedaliera, Padua, Italy.
Matthew A BrookeBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Hugh CalkinsDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Domenico CorradoDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua-Azienda Ospedaliera, Padua, Italy.
Firat DuruDepartment of Cardiology, University Heart Center Zurich, Zurich, Switzerland.
Kathleen J GreenDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Daniel P JudgeDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
David KelsellBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Pier D LambiaseUniversity College London & St. Bartholomew's Hospital, London, UK.
William J McKennaInstitute of Cardiovascular Science, University College London, London, UK.
Kalliopi PilichouDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua-Azienda Ospedaliera, Padua, Italy.
Alexandros ProtonotariosUniversity College London & St. Bartholomew's Hospital, London, UK.
Jeffrey E SaffitzDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA.
Petros SyrrisInstitute of Cardiovascular Science, University College London, London, UK.
Hari TandriDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anneline Te RieleDivision of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Gaetano ThieneDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua-Azienda Ospedaliera, Padua, Italy.
Adalena TsatsopoulouNikos Protonotarios Medical Centre, Naxos, Greece.
J Peter van TintelenDepartment of Clinical Genetics, Amsterdam Cardiovascular Sciences, University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
University College London · GBUniversity of Padua · ITJohns Hopkins University · USQueen Mary University of London · GBAzienda Ospedaliera di Padova · ITHarvard University · USMedical University of South Carolina · USNanoAffix Science (United States) · USNorthwestern University · USOnassis Cardiac Surgery Center · GRSt Bartholomew's Hospital · GBSt George's, University of London · GBUniversity Medical Center Utrecht · NLUniversity of Amsterdam · NLZurich Heart House · CH

Funding

DESMOPLAKIN FUNCTION IN EPIDERMISR01AR043380 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Kathleen Janee Green · 1996 to 2026
$7.0M
Desmoplakin Assembly and Function in EpidermisR37AR043380 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREEN, KATHLEEN JANEE · 2011 to 2020
$4.6M
British Heart Foundation RG/13/19/30568Fondazione Internazionale MenariniNIAMS NIH HHS R01 AR043380NIAMS NIH HHS R37 AR043380
6 · The paper itself

Abstract

It is 35 years since the first description of arrhythmogenic right ventricular cardiomyopathy (ARVC) and more than 20 years since the first reports establishing desmosomal gene mutations as a major cause of the disease. Early advances in the understanding of the clinical, pathological and genetic architecture of ARVC resulted in consensus diagnostic criteria, which proved to be sensitive but not entirely specific for the disease. In more recent years, clinical and genetic data from families and the recognition of a much broader spectrum of structural disorders affecting both ventricles and associated with a propensity to ventricular arrhythmia have raised many questions about pathogenesis, disease terminology and clinical management. In this paper, we present the conclusions of an expert round table that aimed to summarise the current state of the art in arrhythmogenic cardiomyopathies and to define future research priorities.

Indexed as

ConsensusAnti-Arrhythmia AgentsArrhythmogenic Right Ventricular DysplasiaElectrocardiographyHumansAnti-Arrhythmia AgentsArrhythmogenic cardiomyopathyArrhythmogenic right ventricular cardiomyopathyVentricular arrhythmias

Identifiers

PMID31210398
PMCPMC6685753
OpenAlexW2953168259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.